A study in the January 2010 <i>Gastroenterology</i> assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres.  Dr. Kuemmerle speaks to senior author Dr. Riad Salem from the Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois.

A study in the January 2010 Gastroenterology assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres. Dr. Kuemmerle speaks to senior author Dr. Riad Salem from the Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois.

A study in the January 2010 <i>Gastroenterology</i> assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres.&nbsp; Dr. Kuemmerle speaks to senior author Dr. Riad Salem from the Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois.

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres

An engaging, informative mix of author interviews and expert commentary on the latest articles from Gastroenterology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.

Share Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres

Sign up to save your podcasts

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres